Literature DB >> 11190017

The epidemiology of retinal vein occlusion: the Beaver Dam Eye Study.

R Klein1, B E Klein, S E Moss, S M Meuer.   

Abstract

PURPOSE: To describe the prevalence and the 5-year incidence of retinal central and branch vein occlusion and associated risk factors.
METHODS: The Beaver Dam Eye Study (n = 4,926) is a population-based study in which retinal vein occlusions were detected at baseline (1988-1990) and at a 5-year follow-up examination (1993-1995) by grading of 30 degrees color fundus photographs.
RESULTS: The prevalence and 5-year incidence of retinal branch vein occlusion were each 0.6%. The prevalence of retinal central vein occlusion was 0.1%, and the 5-year incidence was 0.2%. While adjusting for age, the prevalence of branch vein occlusion was associated with hypertension (odds ratio [OR] 5.42, 95% confidence interval [CI] 2.18, 13.47), diabetes mellitus (OR 2.43, 95% CI 1.04, 5.70), pulse pressure (OR 1.24 for 10 mm Hg, 95% CI 1.03, 1.48), ocular perfusion pressure (OR 2.09 for 10 mm Hg, 95% CI 1.45, 3.01), arteriovenous nicking (OR 16.75, 95% CI 7.33, 38.24), and focal arteriolar narrowing (OR 22.86, 95% CI 8.43, 62.03). The age-adjusted incidence of retinal branch vein occlusion was associated with current smoking (OR 4.43 95%, CI 1.53, 12.84) compared with nonsmokers and to focal arteriolar narrowing (OR 5.24, 95% CI 1.97, 13.94) at baseline. While controlling for age, the incidence of branch vein occlusion was not associated with serum lipid levels, body mass index, white blood cell count, alcohol consumption, aspirin use, glaucoma, intraocular pressure, or ocular hypertension.
CONCLUSIONS: Retinal vein occlusion is infrequent in the population. These data suggest a strong association between retinal branch vein occlusion and retinal arteriolar changes. Data from larger populations are needed to further assess associations between risk factors and the incidence of retinal vein occlusions.

Entities:  

Mesh:

Year:  2000        PMID: 11190017      PMCID: PMC1298220     

Source DB:  PubMed          Journal:  Trans Am Ophthalmol Soc        ISSN: 0065-9533


  37 in total

1.  Risk factors for retinal vein occlusions. A case-control study.

Authors:  E Z Rath; R N Frank; D H Shin; C Kim
Journal:  Ophthalmology       Date:  1992-04       Impact factor: 12.079

2.  Anterior location of the crossing artery in branch retinal vein obstruction.

Authors:  J S Duker; G C Brown
Journal:  Arch Ophthalmol       Date:  1989-07

3.  Arterial insufficiency in retinal venous occlusion (a short symposium).

Authors:  A Paton; K Rubinstein; V H Smith
Journal:  Trans Ophthalmol Soc U K       Date:  1964

4.  Ocular factors in the incidence and progression of diabetic retinopathy.

Authors:  S E Moss; R Klein; B E Klein
Journal:  Ophthalmology       Date:  1994-01       Impact factor: 12.079

5.  Retinal vein occlusion and the prevalence of lipoprotein abnormalities.

Authors:  P M Dodson; D J Galton; A M Hamilton; R K Blach
Journal:  Br J Ophthalmol       Date:  1982-03       Impact factor: 4.638

6.  Prevalence and associations of retinal vein occlusion in Australia. The Blue Mountains Eye Study.

Authors:  P Mitchell; W Smith; A Chang
Journal:  Arch Ophthalmol       Date:  1996-10

7.  Arteriovenous crossing patterns in branch retinal vein occlusion. The Eye Disease Case-Control Study Group.

Authors:  J Zhao; S M Sastry; R D Sperduto; E Y Chew; N A Remaley
Journal:  Ophthalmology       Date:  1993-03       Impact factor: 12.079

8.  Diabetes mellitus and retinal vein occlusion in patients of Asian, west Indian and white European origin.

Authors:  P M Dodson; E E Kritzinger; C G Clough
Journal:  Eye (Lond)       Date:  1992       Impact factor: 3.775

9.  The Beaver Dam Eye Study: visual acuity.

Authors:  R Klein; B E Klein; K L Linton; D L De Mets
Journal:  Ophthalmology       Date:  1991-08       Impact factor: 12.079

10.  The Beaver Dam Eye Study. Retinopathy in adults with newly discovered and previously diagnosed diabetes mellitus.

Authors:  R Klein; B E Klein; S E Moss; K L Linton
Journal:  Ophthalmology       Date:  1992-01       Impact factor: 12.079

View more
  191 in total

Review 1.  Anti-vascular endothelial growth factor for macular edema secondary to central retinal vein occlusion.

Authors:  Tasanee Braithwaite; Afshan A Nanji; Paul B Greenberg
Journal:  Cochrane Database Syst Rev       Date:  2010-10-06

2.  [Color vision testing in patients with diabetes mellitus and arterial hypertension].

Authors:  S Lüthke; A Welters; S Kropf; I Böckelmann
Journal:  Ophthalmologe       Date:  2010-10       Impact factor: 1.059

Review 3.  Use of bevacizumab for macular edema secondary to branch retinal vein occlusion: a systematic review.

Authors:  Taygan Yilmaz; Miguel Cordero-Coma
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-04-27       Impact factor: 3.117

4.  Prospective multicenter study of visual outcomes following three different treatments for macular edema associated with branch retinal vein occlusion: a study by the Japanese BRVO study group.

Authors:  Seiyo Harino; Kenichiro Bessho; Teruyo Kida
Journal:  Jpn J Ophthalmol       Date:  2012-02-23       Impact factor: 2.447

5.  [The value of acetylsalicylic acid in retinal vein occlusion].

Authors:  B Mazinani; N Plange; P Walter
Journal:  Ophthalmologe       Date:  2010-11       Impact factor: 1.059

6.  Branch retinal vein occlusion: the importance of the topographical distribution of retinal vessels among risk factors.

Authors:  Z Oztas; C Akkin; S Nalcaci; O Ilim; F Afrashi
Journal:  Eye (Lond)       Date:  2017-01-13       Impact factor: 3.775

7.  Comparison of intravitreal bevacizumab with intravitreal triamcinolone acetonide for treatment of cystoid macular edema secondary to retinal vein occlusion: a Meta-analysis.

Authors:  Yan Sun; Yi Qu
Journal:  Int J Ophthalmol       Date:  2015-12-18       Impact factor: 1.779

8.  Surgical induction of chorioretinal venous anastomosis in ischaemic central retinal vein occlusion: a non-randomised controlled clinical trial.

Authors:  A Mirshahi; R Roohipoor; A Lashay; S F Mohammadi; M R Mansouri
Journal:  Br J Ophthalmol       Date:  2005-01       Impact factor: 4.638

9.  Influence of diabetes and diabetes type on anatomic and visual outcomes following central rein vein occlusion.

Authors:  J G Santiago; S Walia; J K Sun; J D Cavallerano; Z A Haddad; L P Aiello; P S Silva
Journal:  Eye (Lond)       Date:  2014-02-14       Impact factor: 3.775

10.  Impaired aortic stiffness and pulse wave velocity in patients with branch retinal vein occlusion.

Authors:  Aysel Aydin Kaderli; Berkant Kaderli; Sumeyye Gullulu; Remzi Avci
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-03       Impact factor: 3.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.